Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carolin Lackner

Showing results (1-10 of 103) with videos related to

Pageof 11
Sort By:
Expert Review of Gastroenterology & Hepatology|April 12, 2011
Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist's perspectiveCarolin Lackner
Journal of Hepatology|January 20, 2019
Fibrosis and alcohol-related liver diseaseCarolin Lackner, Dina Tiniakos
Annals of Hepatology|February 25, 2017
Perspectives on NASH Histology: Cellular BallooningStephen Caldwell, Carolin Lackner
European Journal of Gastroenterology & Hepatology|September 9, 2005
Clinical and genetic criteria are important for identification and management of hereditary non-polyposis colorectal cancerCarolin Lackner, Gerald Hoefler
World Journal of Gastroenterology|August 22, 2007
Noninvasive diagnosis of hepatic fibrosis in chronic hepatitis CRudolf-E Stauber, Carolin Lackner
Journal of Hepatology|September 19, 2021
Reply to: "Prognostic value of histologic parameters in alcoholic hepatitis: A word of caution"Carolin Lackner, Rudolf E Stauber, Dina Tiniakos
Seminars in Liver Disease|September 18, 2015
Diagnosis and Assessment of NAFLD: Definitions and Histopathological ClassificationAlastair D Burt, Carolin Lackner, Dina G Tiniakos
Expert Review of Gastroenterology & Hepatology|April 12, 2011
The cytoskeleton in nonalcoholic steatohepatitis: 100 years old but still youthfulAgnes Molnar, Johannes Haybaeck, Carolin Lackner, et al.
Journal of Hepatology|January 11, 2026
Reply to "MASLD fibrosis stage F3 is morphologically and transcriptomically diverse: implications for assessing therapeutic response" by Chaoyi Li, Quan H. Nguyen, Katharine Irvine, Elizabeth E. Powell, Andrew CloustonCarolin Lackner, Annette S H Gouw, Dina G Tiniakos
Current Drug Safety|June 25, 2013
Severe toxic hepatitis associated with dronedaroneStephan Jahn, Gernot Zollner, Carolin Lackner, et al.
Pageof 11

Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
Expert Review of Gastroenterology & Hepatology|April 12, 2011
Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist's perspectiveCarolin Lackner
Journal of Hepatology|January 20, 2019
Fibrosis and alcohol-related liver diseaseCarolin Lackner, Dina Tiniakos
Annals of Hepatology|February 25, 2017
Perspectives on NASH Histology: Cellular BallooningStephen Caldwell, Carolin Lackner
European Journal of Gastroenterology & Hepatology|September 9, 2005
Clinical and genetic criteria are important for identification and management of hereditary non-polyposis colorectal cancerCarolin Lackner, Gerald Hoefler
World Journal of Gastroenterology|August 22, 2007
Noninvasive diagnosis of hepatic fibrosis in chronic hepatitis CRudolf-E Stauber, Carolin Lackner
Journal of Hepatology|September 19, 2021
Reply to: "Prognostic value of histologic parameters in alcoholic hepatitis: A word of caution"Carolin Lackner, Rudolf E Stauber, Dina Tiniakos
Seminars in Liver Disease|September 18, 2015
Diagnosis and Assessment of NAFLD: Definitions and Histopathological ClassificationAlastair D Burt, Carolin Lackner, Dina G Tiniakos
Expert Review of Gastroenterology & Hepatology|April 12, 2011
The cytoskeleton in nonalcoholic steatohepatitis: 100 years old but still youthfulAgnes Molnar, Johannes Haybaeck, Carolin Lackner, et al.
Journal of Hepatology|January 11, 2026
Reply to "MASLD fibrosis stage F3 is morphologically and transcriptomically diverse: implications for assessing therapeutic response" by Chaoyi Li, Quan H. Nguyen, Katharine Irvine, Elizabeth E. Powell, Andrew CloustonCarolin Lackner, Annette S H Gouw, Dina G Tiniakos
Current Drug Safety|June 25, 2013
Severe toxic hepatitis associated with dronedaroneStephan Jahn, Gernot Zollner, Carolin Lackner, et al.
Pageof 11